•Abingdon Health Plc (LSE:ABDX) advanced +4.55% on 5 October 2026, placing the stock among the session’s notable risers.
Eden BioSolutions PLC (LSE:EDEN) advanced 3.45% on 5 October 2026, placing the stock among the session’s notable UK gainers.
NIOX Group specialises in point-of-care testing of fractional exhaled nitric oxide, known as FeNO, a measure used in the assessment and management of airway inflammation such as asthma. According to its interim report, the company sells in more than 50 countries across the Americas, …
Fusion is an AIM-quoted contract services organisation that helps pharmaceutical and biotechnology customers discover, humanise and optimise antibodies. Its services cover antibody discovery, humanisation and optimisation. Alongside this work, it is developing proprietary platforms and a designed-antibody range branded "Opti", with the aim of …
Ondine Biomedical is a Canadian company quoted on AIM under the ticker OBI. Its lead product, Steriwave, is a nasal photodisinfection treatment that uses light-activated technology to reduce bacteria in the nose before surgery or in intensive care, with the aim of lowering hospital-acquired …
BSF Enterprise is listed on theLondon Stock Exchangeunder the ticker BSFA. It operates through three wholly owned subsidiaries. 3D Bio-Tissues works on cell culture products for regenerative medicine and cultivated meat, including its CytoBoost range. Lab-Grown Leather develops tissue-engineered leather using what it calls …
Surgical Innovations Group is quoted on AIM under the ticker SUN. It designs and manufactures its own SI-branded instruments for laparoscopic and other minimally invasive procedures, makes products for other device companies through an OEM business, and distributes third-party products in the UK through …
Bioventix is quoted on AIM under the ticker BVXP. It develops high-affinity sheep monoclonal antibodies that are used in blood tests run on automated clinical diagnostic analysers. According to the company, its customers include "the majority of multinational clinical diagnostics companies", among them Roche, …
Feedback develops software for the NHS. Its main product, Bleepa, is described by the company as a collaboration platform designed to improve the quality and productivity of patient pathways. It connects existing digital systems and allows clinicians to work asynchronously, which the company says …
Verici Dx develops and sells diagnostic tests intended to help clinicians manage kidney transplant patients. Its commercial product, Tutivia, is a test used after transplantation, and the company is also developing Protega, a further test on its pipeline, and TranscripTx, a genetic test it …